Clinical Trial Update: Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating monitoring of metastatic prostate cancer using [18F]DCFPyL PET imaging and blood-based biomarkers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Columbia University | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING